This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2021 Aug 19:12:734320.

doi: 10.3389/fphys.2021.734320. eCollection 2021.

Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy

Mitchel Tate^{1

2}, Darnel Prakoso^{1

3}, Andrew M Willis¹, Cheng Peng¹, Minh Deo¹, Cheng Xue Qin¹, Jesse L Walsh¹, David M Nash¹, Charles D Cohen¹, Alex K Rofe¹, Arpeeta Sharma⁴, Helen Kiriazis⁵, Daniel G Donner⁵, Judy B De Haan⁴, Anna M D Watson², Miles J De Blasio^{1

3}, Rebecca H Ritchie^{1

2

6}

Affiliations

Affiliations

¹ Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
² Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.
³ School of Biosciences, The University of Melbourne, Melbourne, VIC, Australia.
⁴ Oxidative Stress Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
⁵ Preclinical Cardiology, Microsurgery and Imaging Platform, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
⁶ Department of Pharmacology and Therapeutics, The University of Melbourne, Melbourne, VIC, Australia.

PMID: 34489742
PMCID: PMC8417435
DOI: 10.3389/fphys.2021.734320

Published Erratum

Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy

Mitchel Tate et al. Front Physiol. 2021.

. 2021 Aug 19:12:734320.

doi: 10.3389/fphys.2021.734320. eCollection 2021.

Authors

Mitchel Tate^{1

2}, Darnel Prakoso^{1

3}, Andrew M Willis¹, Cheng Peng¹, Minh Deo¹, Cheng Xue Qin¹, Jesse L Walsh¹, David M Nash¹, Charles D Cohen¹, Alex K Rofe¹, Arpeeta Sharma⁴, Helen Kiriazis⁵, Daniel G Donner⁵, Judy B De Haan⁴, Anna M D Watson², Miles J De Blasio^{1

3}, Rebecca H Ritchie^{1

2

6}

Affiliations

¹ Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
² Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.
³ School of Biosciences, The University of Melbourne, Melbourne, VIC, Australia.
⁴ Oxidative Stress Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
⁵ Preclinical Cardiology, Microsurgery and Imaging Platform, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
⁶ Department of Pharmacology and Therapeutics, The University of Melbourne, Melbourne, VIC, Australia.

PMID: 34489742
PMCID: PMC8417435
DOI: 10.3389/fphys.2021.734320

Abstract

[This corrects the article DOI: 10.3389/fphys.2019.01395.].

Keywords: cardiac; diabetes; diabetic cardiomyopathy; experimental model; type 2 diabetes.

Copyright © 2021 Tate, Prakoso, Willis, Peng, Deo, Qin, Walsh, Nash, Cohen, Rofe, Sharma, Kiriazis, Donner, De Haan, Watson, De Blasio and Ritchie.

PubMed Disclaimer

Figures

Figure 1
Effect of experimental diabetes (combining low-dose STZ and high fat diet) on metabolic characteristics. (A) Body weight, (B) lean mass, (C) fat mass, (D) blood glucose, (E) percentage glycated haemoglobin (HbA1c) and (F) LV Slc2a4 gene expression (glucose transporter GLUT4). Intraperitoneal glucose tolerance test (IPGTT) at (G) 18 weeks and (H) 26 weeks. Plasma (I) insulin, (J) C-peptide levels and (K) cholesterol at 26 weeks. Data are presented as mean ± SEM. n = 9–33 per group (note individual data points). Data analysed using unpaired t-test. ^*p < 0.05, ^**p < 0.01, ^***p < 0.001, ^****p < 0.0001 compared to ND. Blue circles ND; red squares T2DM. ND, non-diabetic; T2DM, type 2 diabetes; HbA1c, glycated haemoglobin; LV, left ventricle; STZ, streptozotocin, AUC, area-under-the-curve.

See this image and copyright information in PMC

Erratum for

Characterising an Alternative Murine Model of Diabetic Cardiomyopathy.
Tate M, Prakoso D, Willis AM, Peng C, Deo M, Qin CX, Walsh JL, Nash DM, Cohen CD, Rofe AK, Sharma A, Kiriazis H, Donner DG, De Haan JB, Watson AMD, De Blasio MJ, Ritchie RH. Tate M, et al. Front Physiol. 2019 Nov 14;10:1395. doi: 10.3389/fphys.2019.01395. eCollection 2019. Front Physiol. 2019. PMID: 31798462 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources